本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BridgeBio Pharma, Inc.

68.39
-3.9900-5.51%
盤後68.390.00000.00%19:30 EDT
成交量:399.30萬
成交額:2.75億
市值:133.91億
市盈率:-19.16
高:72.41
開:72.26
低:66.96
收:72.38
52周最高:93.42
52周最低:48.78
股本:1.96億
流通股本:1.67億
量比:1.80
換手率:2.39%
股息:- -
股息率:- -
每股收益(TTM):-3.5686
每股收益(LYR):-3.7850
淨資產收益率:-1789.67%
總資產收益率:-26.00%
市淨率:-5.32
市盈率(LYR):-18.07

資料載入中...

2026/09/01

重要事件披露

Form 8-K - Current report
2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/17

重要事件披露

Form 8-K - Current report
2026/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/03

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/23

重要事件披露

Form 8-K - Current report
2026/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/02

重要事件披露

Form 8-K - Current report
2026/06/26

重要事件披露

Form 8-K - Current report
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities